Zacks Investment Research
05 Aug 2026, 12:46 UTC · 1h ago
CVS Health (CVS) Q2 Earnings and Revenues Beat Estimates
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
05 Aug 2026, 12:46 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
CVS Health reported quarterly earnings of $2.58 per share, beating the Zacks Consensus Estimate of $1.87 per share by 37.97%. — A significant earnings beat typically triggers immediate positive price action as it indicates stronger-than-expected profitability.
+0.60CVS Health reported quarterly revenues of $106.1 billion, surpassing the Zacks Consensus Estimate by 5.91%. — Revenue growth and an estimate beat confirm top-line health, supporting the sustainability of the earnings beat.
+0.40CVS Health has surpassed consensus EPS and revenue estimates for four consecutive quarters. — Consistent outperformance suggests a reliable trend of operational strength, reducing perceived risk for investors.
+0.30Which stocks this story touches
Continue reading
6 related stories
Top 2 movers · tap to explore
Company beat quarterly earnings and revenue estimates significantly, showing a 37.97% earnings surprise.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
